Endometrial Sarcoma With Renal Metastasis: A Case Report
Article Sidebar
Views | PDF/EPUB Downloads:
12
/ 6
Main Article Content
Abstract
The case of a 30 year old lady that presented with 2 year history of vaginal bleeding and diagnosed as a case of endometrial sarcoma with right renal metastasis has been presented. The diagnosis made from ultrasound and computed tomography was histologically
confirmed. The literature on the condition has been reviewed.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
How to Cite
References
1. Ueda M, Otsuka M, Hatakenaka M. MR Imaging Findings of Uterine Endometrial Stromal Sarcoma: Differentiation from Endometrial Carcinoma. Eur Radiol. 2001; 11: 28-33.
2. Wolfgang Dahnert M.D. Radiology rd Review Manual. 1996; 3 Edition, Williams and Wilkins Co. Baltimore Maryland USA. pp 746.
3. Ueda M. , Otsuka M, Hatakenaka M. Uterine Endometrial Stromal Sarcoma Located in Uterine Myometrium: MRI Appearance. Eur Radiol. 2000; 10: 780 782
4. Gandolfo N, Gandolfo NG, Serafini G. Endometrial Stromal Sarcoma of the Uterus: MR and US Findings, Eur Raidol. 2000; 10: 776 779.
5. Forney JP, Buschbaum HJ: Classifying, Staging, and Treating Uterine Sarcomas. Contemp Ob Gyn, 1998; 18: 47 50, 55 56, 61 62, 64, 69.
6. Shepherd JH: Revised FIGO Staging for Gynaecological Cancer. Br J Obstet, Gynaecol, 1989; 96 : 889-892.
7. Major FJ, Blessing JA, Silverberg SG: Prognostic factors in early-stage uterine sarcoma. A Gynaecologic Oncology Group Study. Cancer 71,
1993: 1702 9.
8. Thigpen JT, Blessing HA, Beecham J: Phase II Trial of Cisplatin as First- Line Chemotherapy in Patients with advanced or recurrent Uterine
Sarcomas: A Gynaecologic Oncology Group Study. J Clin Oncol, 1991; 9: 1962 6.
9. Omura GA, Blessing JA, Major FJ, Homesley H, Yordan E. A randomized clinical trail of adjuvant adriamycin in Uterine Sarcomas: A
Gynaecologic Oncology Group Study. J Clin Oncol 1985; 3: 1240 5.
10. Piver MS, Lele SB, Marchetti DL. Effect of adjuvant Chemotherapy on Time to Recurrence and Survival of Stage I Uterine Sarcomas. J Surg
Oncol, 1988; 38: 233 9.
11.Van Nagell JR, Jr, Hanson MB, Donaldson ES. Adjuvant Vincristine, Dactinomycin, and Cyclophosphamide Therapy in Stage I Uterine Sarcomas. A Pilot Study. Cancer 57, 1986; 57: 1451 4.
12. Peters WA, Rirkin SE, Smith MR. Cisplatin and Adriamycin Combination Chemotherapy for Uterine Stromal Sarcomas and Mixed Mesodermal Tumors. Gynaecol Oncol, 1989; 34: 323 7.